DIDan Ilges

Dan Ilges

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dan Ilges has a total of 129 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • From policing to partnerships: Implementation of a handshake antimicrobial stewardship program

    by Drew T Dickinson, Jenna Reynolds, Sandhya R Nagarakanti, Jamilah Shubeilat, Adrijana Anderson, Viet Do, Valerie L Armstrong, Luke DeGraaff, Pete Johnston, Juli Kelly, et al.

    Purpose: Handshake antimicrobial stewardship (HAS) facilitates professional relationship building while ensuring safe and appropriate antimicrobial use. Development of a pharmacist-physician co-led HAS program requires interdisciplinary collaboration and coordination. In this case study, we describe our experience establishing a HAS program across 2 service lines. Summary: A quality improvement framework was used to identify partnering services and program outcome metrics for HAS. Service lines with high antimicrobial utilization and/or limited antimicrobial stewardship contact were identified. Stewardship champions within partner service lines were identified to assist with HAS scheduling, coordination, and socialization. HAS programs were established with the hospital medicine and acute care surgery service lines and executed as scheduled once-weekly face-to-face rounds and review of all patients on systemic antimicrobials. One year post implementation, acceptance of HAS recommendations was greater than 80% for both services. Broad-spectrum antibiotic use decreased, and communication with stewardship pharmacists increased among intervention service lines. Program outcomes were communicated to quality and hospital leadership. Providers expressed high satisfaction with the HAS programs. Conclusion: Creation of an HAS program requires data-informed, interdisciplinary collaboration between pharmacy, antimicrobial stewardship, administration, and partner prescribers and service lines. HAS facilitates stewardship efforts and simultaneously promotes stronger professional relationships with prescribers. Through regular face-to-face interactions with pharmacists via HAS, prescribers incorporate antimicrobial stewardship into daily practice and appreciate antimicrobial stewards as partners in advancing patient care.

  • Retrospective Evaluation of the Association of Hypoalbuminemia With Acute Treatment Outcomes in Methicillin-Susceptible Staphylococcus Aureus Bacteremia

    by Ryan W. Stevens, Daniel C. DeSimone, Kyle A. Hess, Joya-Rita Hindy, Kristin Cole, Kirstin Kooda, John C. Robinson, Larry M. Baddour, Dan Ilges

    Background: Cefazolin and antistaphylococcal penicillins (ASP) are first-line agents for methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia. These agents are substantially protein-bound; however, scant data exist evaluating the impact of hypoalbuminemia on microbiologic and patient outcomes for this indication. Objective: The purpose of this study was to assess whether hypoalbuminemia is associated with delayed blood culture clearance in patients with MSSA bacteremia being treated with cefazolin or ASPs as definitive therapy. Methods: This retrospective cohort study included patients admitted for MSSA bacteremia between January 1, 2006 and December 31, 2019, with a serum albumin obtained between the date of an initial positive blood culture result and 72 hours following initiation of definitive therapy with cefazolin or an ASP. The primary outcome was the rate of persistently positive blood cultures, defined as failure to clear blood cultures within 72 hours of definitive therapy initiation. Patients with a serum albumin ≤2.5 g/dL were compared with those with an albumin >2.5 g/dL. Propensity score weighting was used to account for differences in cohort characteristics. Results: A total of 123 patients were included. After propensity score weighting, patients with hypoalbuminemia had a higher rate of persistently positive blood cultures, both in the overall cohort (45.0% vs 13.2%, P < .001) and in the subgroups of cefazolin (33.0% vs 9.1%, P = .015) and ASP (60.1% vs 18.3%, P = .001) when analyzed separately. After propensity weighting in the combined cohort, the length of stay was longer in the hypoalbuminemic cohort, but no differences in mortality were observed. Conclusions and Relevance: Hypoalbuminemia was associated with a delayed 72-hour blood culture clearance in patients with MSSA bacteremia treated with either cefazolin or ASPs.

  • Open Access

    Risk Factors Associated With Positive Intraoperative Valve Tissue Cultures and the Subsequent Impact on Infective Endocarditis Management and Outcomes

    by Nirjan Bhattarai, Ryan W Stevens, Larry M Baddour, Daniel C DeSimone, Supavit Chesdachai, Joya-Rita Hindy, Ross A Dierkhising, Dan Ilges

    Background: Cardiac valve tissue obtained during the surgical management of infective endocarditis (IE) and sent for culture may influence postoperative antibiotic therapy. We sought to identify clinical and microbiologic risk factors associated with positive valve cultures (PVCs) and IE relapses in a cohort of patients undergoing surgical management. Methods: This is a retrospective, multicenter study of patients with surgical management during the acute course (<42 days) of IE-directed antibiotic therapy. The rate of PVC, IE relapse, and mortality were collected. Univariate and multivariable logistic regressions were performed to identify risk factors associated with PVC. Results: Of 113 patients included, 36 (31.9%) had PVCs. Univariate and multivariable analyses showed that preoperative antibiotic duration and pathogens were associated with PVC. The median number of days of preoperative antibiotics was 6.5 (interquartile range [IQR], 4.0–11.0) for patients with PVCs compared to 13.0 (IQR, 8.0–21.0) for those with negative valve cultures (NVCs). In a multivariable model, preoperative antibiotic administration decreased the risk of PVC (odds ratio [OR], 0.85 per day [95% CI, .77–.91]). Enterococcal IE increased the risk of PVC compared to streptococcal IE (OR, 4.16 [95% CI, 1.07–17.48]). Of note, 33 (63.2%) patients with NVCs received a median of 8 (IQR, 5–18.5) days of avoidable intravenous antibiotics per patient. Only 1 IE relapse was identified and occurred in a patient with NVCs. Conclusions: Both preoperative antibiotic duration and causative pathogen were associated with PVC. IE relapses were rare and unrelated to PVC. There may be an opportunity to shorten postoperative antibiotic durations following surgical management in patients with IE.

  • Open Access

    Risk factors for methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa community-acquired pneumonia at a high-volume transplant center

    by Evan K. Mallory, Drew T. Dickinson, Dylan Kosaski, Jacob Schwarz, Emily Thompson, Sandhya R. Nagarakanti, M. Teresa Seville, Dan Ilges

    Objective: To validate risk factors for methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa in patients hospitalized with community-acquired pneumonia (CAP). Design: Retrospective, single-center, cohort study from October 1, 2018, to March 31, 2023. Setting: Mayo Clinic Hospital in Phoenix, AZ. Participants: Adult patients with CAP, identified using ICD-10 diagnosis codes, receipt of systemic antibiotics for a “respiratory tract infection” within 48 hours of hospitalization, and availability of respiratory cultures. Methods: Multivariate logistic regression was used to identify factors independently associated with MRSA or P. aeruginosa isolation in respiratory cultures. Results: A total of 1,485 patients met inclusion criteria; 32 (2.2%) had MRSA and 81 (5.5%) had P. aeruginosa isolated from respiratory culture. Multivariate logistic regression analyses identified substance use disorder [aOR 8.29, P < .001], influenza [aOR 7.64, P = .003], lung abscess/empyema [aOR 4.58, P = .031], and peptic ulcer disease (PUD) [aOR 4.09, P = .017] as MRSA risk factors. Bronchiectasis [aOR 3.67, P < .001], PUD [aOR 3.48, P = .006], and COPD [aOR 2.60, P = .005] were independently associated with P. aeruginosa . Immunocompromised conditions, including transplantation (solid organ and hematopoietic stem cell) and malignant tumor were not independently associated with either organism. Conclusions: Our results substantiate previously demonstrated risk factors for MRSA and P. aeruginosa in CAP. We did not observe an independent association between immunosuppressed conditions evaluated and isolation of MRSA or P. aeruginosa .

  • Open Access

    Ambulatory antibiotic prescribing for acute sinusitis: a multicenter, retrospective cohort study evaluating appropriateness

    by Kellie Arensman Hannan, Dan Ilges, Kimberly T. Le, Kristin Cole, Ryan W. Stevens, Kelsey Jensen

    Objective: Antibiotics are frequently prescribed for acute sinusitis despite national guidelines recommending antibiotics only if specific symptom criteria are met. We aimed to define the proportion of acute sinusitis encounters meeting criteria for antibiotic prescribing, characterize prescribing practices, and identify factors associated with guideline-discordant prescribing. Design: This retrospective cohort study included 1,000 randomly selected adult ambulatory encounters with a primary diagnosis of acute sinusitis between January 1, 2024 and March 31, 2024. Encounter notes were reviewed for appropriate antibiotic prescribing criteria as per national guidelines. Encounters were evaluated for drug selection and duration concordance based on local guidelines. A multivariable logistic regression analysis was performed to identify predictors of inappropriate antibiotic prescribing. Setting: Emergency departments, urgent care centers, and primary care clinics. Results: Antibiotic prescribing criteria were met for 67.6% of included encounters. Antibiotics were prescribed in 93.5% of encounters that met prescribing criteria, and 80.2% of encounters that did not. Both drug selection and duration were guideline-concordant in 49.2% of total encounters. On multivariable analysis, predictors of inappropriate antibiotic prescribing included cough (OR 2.15, 95% CI 1.08–4.29; P = 0.03) and symptom duration between 7 and 9 days (compared to P < 0.001). Electronic encounters were associated with lower odds of prescribing compared to in-person encounters (OR 0.03, 95% CI 0.01–0.09; P < 0.001). Conclusions: Most encounters for acute sinusitis result in an antibiotic prescription, despite prescribing criteria not being met. These findings may aid antimicrobial stewardship programs in benchmarking and optimizing antibiotic prescribing for acute sinusitis.


  • Open Access

    Point-Counterpoint: Should MRSA nares testing be used as a tool for vancomycin de-escalation outside of pneumonia?

    by Dan Ilges, Drew T. Dickinson, Jennifer M. Bosquez, Erin H. Graf

    Vancomycin is broadly used to treat gram-positive infections in both inpatient and outpatient settings. Its use is primarily for the treatment of methicillin-resistant Staphylococcus aureus (MRSA), which is a common cause of pneumonia, skin and soft tissue infections, and bloodstream infections. Vancomycin therapy requires close clinical monitoring to maintain therapeutic efficacy and, importantly, patient safety. Vancomycin use is associated with acute kidney injury in up to 20% of cases, a number that can be driven down by pharmacokinetic dosing protocols. However, the best mitigation against adverse outcomes associated with vancomycin is to ensure it is only used when needed and rapidly de-escalated when not. As such, many stewardship programs, who are tasked with the safe and effective use of antimicrobial agents, have focused on optimizing vancomycin use. There is a strong correlation with MRSA colonization and infection, and a negative MRSA nares screen has a good negative predictive value for MRSA pneumonia (although this association is less well documented for other infections). As such, detection of MRSA in nares swabs, by nucleic acid amplification tests (NAATs) or culture, is a logical tool for stewarding vancomycin. However, the application of MRSA screening tests as MRSA diagnostics is complex, as these tests are cleared by the U.S. Food and Drug Administration for the detection of MRSA colonization, and not for therapeutic decision making. In this issue of the Journal of Clinical Microbiology, the issue of MRSA nares tests is debated by a clinical pharmacy team and the laboratory. The authors review the clinical evidence and regulatory background in which an MRSA nares NAAT may be used to inform treatment decisions.

  • Open Access

    Fosmanogepix Treatment for Coccidioidomycosis Under an Expanded Access Program

    by Stuart H Cohen, Paul Allyn, Felicia C Chow, Jennifer Rathe, Deepa D Nanayakkara, Gerald Hutfles, Tara Vijayan, Ethan A Smith, Christopher F Saling, Dan Ilges, et al.

    Coccidioidomycosis is an invasive fungal infection that can disseminate and cause severe disease. Fosmanogepix (“gepix”), a first-in-class antifungal available via expanded access (NCT06433128), was successful in 8/11 patients (meningitis, 6/8 [75%]; nonmeningeal dissemination, 2/3 [66%]) and was well tolerated for a median treatment duration of 208 days.


  • Impact of positive donor blood cultures on solid organ transplant recipient outcomes

    by Edith Ford, Cassandra Votruba, Christopher Saling, Holenarasipur Vikram, Dan Ilges

    Objective: To define the incidence of donor-derived infection (DDI) in recipients of solid organ transplant (SOT) from donors with positive blood cultures and to assess the impact of shorter versus longer duration of targeted preemptive antibiotic therapy (PAT). Design: Retrospective, single-center, cohort study. Setting: Mayo Clinic Arizona. Patients: Recipients transplanted between 1/1/2019 and 7/1/2024 who received an organ from a donor with positive blood cultures. Methods: The primary outcome was incidence of DDI. Secondary outcomes included duration of PAT and incidence of donor blood culture contamination. Results: Among 199 SOT recipients from 167 unique donors with positive blood cultures, two recipients developed confirmed DDI within 30 days of SOT. Both cases were gram negative bacillary bacteremia not treated in donors and occurred immediately posttransplant prior to adequate recipient PAT. Six-month graft survival and recipient survival were 96.5% and 97.5% respectively. 139 recipients (69.8%) received PAT for a median duration of 7 days. There was no difference in rate of infections between recipients provided with ≤7 days versus 8–14 days of PAT for donor blood cultures; however, recipients who received 8–14 days had more Clostridioides difficile infections (CDIs) within 60 days of SOT (7.7% vs 1.5% ≤ 7 days, P = .040) and were more often discharged on intravenous antibiotics (32.3% vs 11.3%, P < .001). Conclusion: We observed a low rate of DDI following receipt of organs from donors with positive blood cultures. DDI occurred in cases without adequate donor/recipient treatment. Longer durations of targeted PAT resulted in more CDI and intravenous antibiotics on discharge.